The 8 analysts offering 12-month price forecasts for Autolus Therapeutics PLC have a median target of 25.50, with a high estimate of 50.00 and a low estimate of 13.00. The median estimate represents a +61.19% increase from the last price of 15.82.
The current consensus among 9 polled investment analysts is to Buy stock in Autolus Therapeutics PLC. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.71
Reporting Date Nov 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.